{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:49:35Z","timestamp":1790794175256,"version":"4.1.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dexamethasone improves the survival of COVID-19 patients in need of supplemental oxygen therapy. Although its broad immunosuppressive effects are well-described, the immunological mechanisms modulated by dexamethasone in patients hospitalized with COVID-19 remain to be elucidated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We combined functional immunological assays and an omics-based approach to investigate the <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> effects of dexamethasone in the plasma and peripheral blood mononuclear cells (PBMCs) of COVID-19 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Hospitalized COVID-19 patients eligible for dexamethasone therapy were recruited from the general care ward between February and July, 2021. Whole blood transcriptomic and targeted plasma proteomic analyses were performed before and after starting dexamethasone treatment. PBMCs were isolated from healthy individuals and COVID-19 patients and stimulated with inactivated SARS-CoV-2 <jats:italic>ex vivo<\/jats:italic> in the presence or absence of dexamethasone and transcriptome and cytokine responses were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Dexamethasone efficiently inhibited SARS-CoV-2-induced <jats:italic>in vitro<\/jats:italic> expression of chemokines and cytokines in PBMCs at the transcriptional and protein level. Dexamethasone treatment in COVID-19 patients resulted in down-regulation of genes related to type I and II interferon (IFN) signaling in whole blood immune cells. In addition, dexamethasone attenuated circulating concentrations of secreted interferon-stimulating gene 15 (ISG15) and pro-inflammatory cytokines and chemokines correlating with disease severity and lethal outcomes, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), chemokine ligand 2 (CCL2), C-X-C motif ligand 8 (CXCL8), and C-X-C motif chemokine ligand 10 (CXCL10). In PBMCs from COVID-19 patients that were stimulated <jats:italic>ex vivo<\/jats:italic> with multiple pathogens or Toll-like receptor (TLR) ligands, dexamethasone efficiently inhibited cytokine responses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We describe the anti-inflammatory impact of dexamethasone on the pathways contributing to cytokine hyperresponsiveness observed in severe manifestations of COVID-19, including type I\/II IFN signaling. Dexamethasone could have adverse effects in COVID-19 patients with mild symptoms by inhibiting IFN responses in early stages of the disease, whereas it exhibits beneficial effects in patients with severe clinical phenotypes by efficiently diminishing cytokine hyperresponsiveness.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1233318","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:09:26Z","timestamp":1691496566000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Job J.","family":"Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caspar I.","family":"van der Made","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Keur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todia","family":"Setiabudiawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger J.","family":"R\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Damoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Lemmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyfallia","family":"Poulakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W. M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.","family":"van de Veerdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new york city area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","article-title":"Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison","volume":"22","author":"Galani","year":"2021","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.cell.2021.01.053","article-title":"COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas","volume":"184","author":"Ren","year":"2021","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","article-title":"A guide to immunotherapy for COVID-19","volume":"28","author":"van de Veerdonk","year":"2022","journal-title":"Nat Med"},{"key":"B11","first-page":"693","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"B12","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis","volume":"324","year":"2020","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"crossref","first-page":"2102532","DOI":"10.1183\/13993003.02532-2021","article-title":"Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support","volume":"60","author":"Crothers","year":"2022","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2016.10.006","article-title":"Functional and genomic architecture of borrelia burgdorferi-induced cytokine responses in humans","volume":"20","author":"Oosting","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cei\/uxac073","article-title":"Identifying platelet-derived factors as amplifiers of B","volume":"210","author":"Kerstholt","year":"2022","journal-title":"burgdorferi-induced Cytokine production. Clin Exp Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Lamontagne","year":"2020","journal-title":"BMJ"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106230","article-title":"SARS-CoV-2 targets neurons of 3D human brain organoids","volume":"39","author":"Ramani","year":"2020","journal-title":"EMBO J"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix120","article-title":"SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data","volume":"7","author":"Chen","year":"2018","journal-title":"Gigascience"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00288","article-title":"Sequencing quality assessment tools to enable data-driven informatics for high throughput genomics","volume":"4","author":"Leggett","year":"2013","journal-title":"Front Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr424","article-title":"Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood","volume":"39","author":"Lundberg","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B24","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with covid-19","volume":"384","author":"Gordon","year":"2021","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0489-5","article-title":"ACOD1 in immunometabolism and disease","volume":"17","author":"Wu","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0277-8","article-title":"The IL-1 family of cytokines and receptors in rheumatic diseases","volume":"15","author":"Dinarello","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060336","article-title":"Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1","volume":"203","author":"Abraham","year":"2006","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.540799","article-title":"Roles for the mitogen-activated protein kinase (MAPK) phosphatase, DUSP1, in feedback control of inflammatory gene expression and repression by dexamethasone","volume":"289","author":"Shah","year":"2014","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"B36","article-title":"Management of C-i. A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25673","article-title":"VSIG4, a B7 family\u2013related protein, is a negative regulator of T cell activation","volume":"116","author":"Vogt","year":"2006","journal-title":"J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-017-01327-4","article-title":"VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"key":"B39","article-title":"(MAO-A): a signature marker of alternatively activated monocytes\/macrophages","volume":"1","author":"Cathcart","year":"2014","journal-title":"Inflamm Cell Signal"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00719","article-title":"Regulation and functions of 15-lipoxygenases in human macrophages","volume":"10","author":"Snodgrass","year":"2019","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41419-019-1325-7","article-title":"SHROOM2 inhibits tumor metastasis through RhoA\u2013ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma","volume":"10","author":"Yuan","year":"2019","journal-title":"Cell Death Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01453-14","article-title":"Rap1 spatially controls arhGAP29 to inhibit rho signaling during endothelial barrier regulation","volume":"35","author":"Post","year":"2015","journal-title":"Mol Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.509158","article-title":"Homeobox transcription factor ventX regulates differentiation and maturation of human dendritic cells*","volume":"289","author":"Wu","year":"2014","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19","volume":"375","author":"Merad","year":"2022","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0020-5","article-title":"ISG15 in antiviral immunity and beyond","volume":"16","author":"Perng","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01056-3","article-title":"ISG15 secretion exacerbates inflammation in SARS-CoV-2 infection","volume":"22","author":"Cao","year":"2021","journal-title":"Nat Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00299-20","article-title":"Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis","volume":"34","author":"Ramasamy","year":"2021","journal-title":"Clin Microbiol Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"155507","DOI":"10.1016\/j.cyto.2021.155507","article-title":"IL-6 and IL-10 are associated with disease severity and higher comorbidity in adults with COVID-19","volume":"143","author":"Luporini","year":"2021","journal-title":"Cytokine"},{"key":"B50","doi-asserted-by":"publisher","first-page":"104370","DOI":"10.1016\/j.jcv.2020.104370","article-title":"Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19","volume":"127","author":"Liu","year":"2020","journal-title":"J Clin Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac313","article-title":"High circulating levels of the homeostatic chemokines CCL19 and CCL21 predict mortality and disease severity in COVID-19","volume":"226","author":"Tveita","year":"2022","journal-title":"J Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","first-page":"109325","DOI":"10.1016\/j.intimp.2022.109325","article-title":"Role of CCL2\/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table","volume":"113","author":"Ranjbar","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.454538","article-title":"Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species","volume":"288","author":"Li","year":"2013","journal-title":"J Biol Chem"},{"key":"B56","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B57","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-coV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"key":"B60","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00421-x","article-title":"After 62 years of regulating immunity, dexamethasone meets COVID-19","volume":"20","author":"Cain","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add4906","article-title":"Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19","volume":"7","author":"Laurent","year":"2022","journal-title":"Sci Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01576-3","article-title":"Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19","volume":"28","author":"Sinha","year":"2022","journal-title":"Nat Med"},{"key":"B66","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-020-0762-x","article-title":"Single-cell landscape of immunological responses in patients with COVID-19","volume":"21","author":"Zhang","year":"2020","journal-title":"Nat Immunol"},{"key":"B67","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2020.10.037","article-title":"Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19","volume":"183","author":"Su","year":"2020","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B69","doi-asserted-by":"crossref","DOI":"10.1038\/s41590-021-01035-8","article-title":"Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection","volume":"22","author":"Munnur","year":"2021","journal-title":"Nat Immunol"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1126\/science.1224026","article-title":"Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency","volume":"337","author":"Bogunovic","year":"2012","journal-title":"Science"},{"key":"B71","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.molcel.2017.10.003","article-title":"Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin receptor","volume":"68","author":"Swaim","year":"2017","journal-title":"Mol Cell"},{"key":"B72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12857","article-title":"Dissociation between systemic and pulmonary anti-inflammatory effects of dexamethasone in humans","volume":"81","author":"Bartko","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"B74","doi-asserted-by":"crossref","first-page":"145665","DOI":"10.1016\/j.gene.2021.145665","article-title":"Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data","volume":"788","author":"Sharma","year":"2021","journal-title":"Gene"},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac218","article-title":"A distinct dexamethasone-dependent gene expression profile in the lungs of COVID-19 patients","volume":"226","author":"Fahnoe","year":"2022","journal-title":"J Infect Dis"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the coDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"B77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13613-022-01074-w","article-title":"Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study","volume":"12","author":"Raymond","year":"2022","journal-title":"Ann Intensive Care"},{"key":"B78","first-page":"CD015308","article-title":"Interleukin-1 blocking agents for treating COVID-19","volume":"1","author":"Davidson","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.06.018","article-title":"Immunoresponsive gene 1 augments bactericidal activity of macrophage-lineage cells by regulating beta-oxidation-dependent mitochondrial ROS production","volume":"18","author":"Hall","year":"2013","journal-title":"Cell Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.09.22278592","article-title":"Distinguishing features of Long COVID identified through immune profiling","author":"Klein","year":"2022","journal-title":"medRxiv"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.17.21266392","article-title":"Impact of dexamethasone on persistent symptoms of COVID-19: an observational study","author":"Milne","year":"2021","journal-title":"medRxiv"},{"key":"B83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jinf.2022.05.015","article-title":"Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation","volume":"85","author":"Sovik","year":"2022","journal-title":"J Infect"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00088-1","article-title":"Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial","volume":"10","author":"Wolfe","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","article-title":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"23","author":"Ni","year":"2019","journal-title":"Crit Care"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1233318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T12:09:43Z","timestamp":1691496583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1233318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":86,"alternative-id":["10.3389\/fimmu.2023.1233318"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1233318","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]},"article-number":"1233318"}}